4.7 Article

A cluster-randomized trial of benchmarking and multimodal quality improvement to improve rates of survival free of bronchopulmonary dysplasia for infants with birth weights of less than 1250 grams

期刊

PEDIATRICS
卷 119, 期 5, 页码 876-890

出版社

AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2006-2656

关键词

quality improvement; randomized trial; bronchopulmonary dysplasia

资金

  1. NCRR NIH HHS [M01 RR00997, M01 RR02635, M01 RR06022, M01 RR00750, M01 RR02172, M01 RR08084, M01 RR01032, M01 RR00070] Funding Source: Medline
  2. NICHD NIH HHS [U10 HD21364, U01 HD36790, U10 HD27851, U10 HD34216, U10 HD21415, U10 HD27853, U10 HD27856, U10 HD21373, U10 HD27904, U10 HD27881, U10 HD21397, U10 HD34167, U10 HD21385, U10 HD27880, U10 HD27871] Funding Source: Medline

向作者/读者索取更多资源

OBJECTIVE. We tested whether NICU teams trained in benchmarking and quality improvement would change practices and improve rates of survival without bronchopulmonary dysplasia in inborn neonates with birth weights of < 1250 g. METHODS. A cluster-randomized trial enrolled 4093 inborn neonates with birth weights of < 1250 g at 17 centers of the National Institute of Child Health and Human Development Neonatal Research Network. Three centers were selected as best performers, and the remaining 14 centers were randomized to intervention or control. Changes in rates of survival free of bronchopulmonary dysplasia were compared between study year 1 and year 3. RESULTS. Intervention centers implemented potentially better practices successfully; changes included reduced oxygen saturation targets and reduced exposure to mechanical ventilation. Five of 7 intervention centers and 2 of 7 control centers implemented use of high-saturation alarms to reduce oxygen exposure. Lower oxygen saturation targets reduced oxygen levels in the first week of life. Despite these changes, rates of survival free of bronchopulmonary dysplasia were all similar between intervention and control groups and remained significantly less than the rate achieved in the best-performing centers (73.3%). CONCLUSIONS. In this cluster-randomized trial, benchmarking and multimodal quality improvement changed practices but did not reduce bronchopulmonary dysplasia rates.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据